MDRX - Investors Sue Veradigm (MDRX) For Inflating Revenues - Hagens Berman | Benzinga

SAN FRANCISCO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. (NASDAQ:MDRX) investors who suffered substantial losses to submit your losses now.

Class Period: Feb. 26, 2021 – June 13, 2023
Lead Plaintiff Deadline: Jan. 22, 2024
Visit: www.hbsslaw.com/investor-fraud/MDRX  
Contact An Attorney Now: MDRX@hbsslaw.com
                                                     844-916-0895

Veradigm Inc. (MDRX) Securities Fraud Class Action:

The complaint alleges Defendants made false and misleading statements and failed to disclose that Veradigm: (1) had overstated its historical revenues by at least $20 million; (2) artificially inflated revenues by recording duplicate transactions over more than 2 years; (3) artificially inflated earnings and margins and materially misrepresented demand for its products and services; (4) failed to maintain sufficient internal controls over its financial reporting; and (5) did not comply with Generally Accepted Accounting Principles regarding revenue recognition practices.

Investors began to learn the truth on Feb. 28, 2023, when Veradigm announced that it would not timely file its Q4 2022 earnings and 2022 ...

MDRX) For Inflating Revenues - Hagens Berman>Full story available on Benzinga.com